US FDA approves Regeneron-Sanofi’s Kevzara to treat polymyalgia rheumatica October 25, 2023 Blog The US Food and Drug Administration (FDA) has granted approval for Regeneron Pharmaceuticals and Sanofi’s Kevzara (sarilumab) to treat polymyalgia rheumatica (PMR) in adult Read More »
